The molecular pathophysiology of obesity-driven ECM remodelling or myocardial fibrosis is attributed to hypoxia, inflammation, activation of renin-angiotensin-aldosterone system, TGF-β signalling, and oxidative stress [35]. The gene discussed is TGFB1; the disease is Myocardial fibrosis.